{"id":"NCT00056160","sponsor":"Celgene","briefTitle":"CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma","officialTitle":"A Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-controlled Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-01-01","primaryCompletion":"2005-11-01","completion":"2008-10-01","firstPosted":"2003-03-07","resultsPosted":"2010-03-03","lastUpdate":"2017-10-19"},"enrollment":353,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"CC-5013","otherNames":["lenalidomide","Revlimid"]},{"type":"DRUG","name":"Dexamethasone","otherNames":["Decadron"]}],"arms":[{"label":"CC-5013/Dex","type":"EXPERIMENTAL"},{"label":"Placebo/Dex","type":"EXPERIMENTAL"}],"summary":"Randomized subjects will receive CC-5013 plus high-dose dexamethasone or placebo appearing identical to CC-5013 plus high-dose dexamethasone in 4-week cycles. Each subject will participate in a treatment phase and a follow-up phase.","primaryOutcome":{"measure":"Time to Tumor Progression (TTP)","timeFrame":"60 weeks (median Time To Progression of CC-5013/Dex treatment group)","effectByArm":[{"arm":"CC-5013/Dex","deltaMin":60.1,"sd":null},{"arm":"Placebo/Dex","deltaMin":20.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":49,"countries":["United States","Canada"]},"refs":{"pmids":["18032763","21273172","19901114","18799726"],"seeAlso":["http://www.celgene.com/research-development/clinical-trials/clinical-trials-data-sharing/clinical-study-report-csr-synopses/purposes-of-posting-clinical-study-report-csr-synopses"]},"adverseEventsSummary":{"seriousAny":{"events":111,"n":177},"commonTop":["FATIGUE","INSOMNIA","DIARRHOEA","NAUSEA","HEADACHE"]}}